Urinary findings in renal light chain-derived amyloidosis and light chain deposition disease

Clinical Lymphoma and Myeloma

Volumn 9, Issue 3, 2009, Pages 234-238

  Melmed, Gavin ^a   Fenves, Andrew ^b   Stone, Marvin ^c  

^a Baylor Medicine Center   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

AL amyloidosis; Albuminuria; Bence Jones proteinuria; LCDD; Urine immunoelectrophoresis; Urine immunofixation

Indexed keywords

BENCE JONES PROTEIN; COLCHICINE; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MELPHALAN; PREDNISONE; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ANEMIA; ARTICLE; AUTOPSY; BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BREAST BIOPSY; CARDIOMYOPATHY; CARPAL TUNNEL SYNDROME; CHRONIC DIARRHEA; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; DEMOGRAPHY; DRUG WITHDRAWAL; FEMALE; GLOMERULOSCLEROSIS; HEADACHE; HEART INFARCTION; HEPATOMEGALY; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOELECTROPHORESIS; IMMUNOGLOBULIN DEFICIENCY; IMMUNOHISTOCHEMISTRY; KIDNEY AMYLOIDOSIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEG EDEMA; LEUKOPENIA; LIGHT CHAIN; LIGHT CHAIN DEPOSITION DISEASE; LOW DRUG DOSE; MALE; MICROSCOPY; MULTIPLE ORGAN FAILURE; PARESTHESIA; PATHOLOGY; PERIPHERAL EDEMA; PLASMA CELL DYSCRASIA; PLASMACYTOSIS; PROTEIN ELECTROPHORESIS; PROTEINURIA; RETROSPECTIVE STUDY; SPLENOMEGALY; STAINING; URINALYSIS; WEAKNESS; AMYLOIDOSIS; DIFFERENTIAL DIAGNOSIS; KIDNEY DISEASE; METHODOLOGY; MIDDLE AGED; MULTIPLE MYELOMA; TREATMENT OUTCOME; URINE;

ADULT; AGED; ALBUMINURIA; AMYLOIDOSIS; BENCE JONES PROTEIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOELECTROPHORESIS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 69149089904     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.046     Document Type: Article

References (21)

1. Stone MJ. Amyloidosis: a final common pathway for protein deposition in tissues. Blood 1990; 75:531-45.
2. Merlini G, Stone MJ. Dangerous small B-cell clones. Blood 2006; 108:2520-30.
3. Guirl MJ, Hogenauer C, Santa Ana CA, et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am J Gastroenterol 2003; 98:2219-25.
4. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995; 32:45-59.
5. DeFronzo RA, Cooke CR, Wright JR, et al. Renal function in patients with multiple myeloma. Medicine (Baltimore) 1978; 57:151-66.
6. Stone MJ, Frenkel EP. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis. Am J Med 1975; 58:601-19.
7. Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58:665-8 3.
8. Stone MJ, Hirsch VJ. Splenic function in amyloidosis. In: Glenner GG, Osserman EF, Benditt EP, et al, eds. Amyloidosis. New York: Plenum Press; 1986:583-90.
9. Westermark P, Benson MD, Buxbaum JN, et al. Amyloid fibril protein nomenclature- 2002. Amyloid 2002; 9:197-200.
10. Glenner GG. Amyloid deposits and amyloidosis: the beta-fibrilloses. N Engl J Med 1980; 302:1283-92.
11. Stone MJ, Guirl MJ. Amyloidosis. In: Johnson LR, ed. Encyclopedia of Gastroenterology. Vol 1. San Diego: Academic Press; 2004:59-69.
12. Sanders PW, Herrera GA, Kirk KA, et al. Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobulin light chain deposition. Lab Invest 1991; 64:527-37.
13. Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasmacell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. N Engl J Med 1974; 290:473-7.
14. Kyle RA, Bayrd ED. Amyloidosis: review of 236 cases. Medicine (Baltimore) 1975; 54:271-99.
15. Rajkumar SV, Gertz MA, Kyle RA. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 1998; 82:1501-5.
16. Palladini G, Perfetti V, Perlini S, et al. The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL). Blood 2005; 105:2949-51.
17. Dispenzieri A, Lacy MQ, Zeldenrust SR, et al. The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood 2007; 109:465-70.
18. Appel GB, Radhakrishnan J, D'Agati VD. Secondary glomerular diseases. In: Brenner BM, ed. Brenner and Rector's The Kidney. 7th ed. Philadelphia, PA: Saunders; 2004:1423.
19. Pozzi C, D'Amico M, Fogazzi GB, et al. Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors. Am J Kidney Dis 2003; 42:1154-63.
20. Kyle RA, Rajkumar SV. Plasma cell disorders. In: Goldman L, Ausiello D, eds. Cecil Textbook of Medicine. 22th ed. Philadelphia, PA: Saunders; 2004:1186.
21. Gertz MA, Lacy MQ, Dispenzieri A, et al. Amyloidosis: diagnosis and management. Clin Lymphoma Myeloma 2005; 6:208-19.